SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

GSK £1bn savings plan to hit manufacture towards 2017, but UK likely immune

23-Oct-2014 - GlaxoSmithKline plans to cut manufacturing, sales and R&D as part of a three year plan to save £1bn ($1.6bn) annually. 

Actavis takes axe to Forest again, with New York jobs to go

23-Oct-2014 - Almost 100 jobs at a commercial packaging facility in New York are set to go as part of Actavis’s continued integration of Forest Laboratories.

Eli Lilly to sell PR plant due to patent expirations and shifting portfolio

20-Oct-2014 - Eli Lilly is set to close one of its Puerto Rican facilities as patent expirations and a shifting portfolio reduce its need for capacity.

Agilent to close NMR unit with loss of 300 jobs

15-Oct-2014 - Agilent Technologies is to exit its Nuclear Magnetic Resonance (NMR) business because it has not met growth and profit targets.

Got questions for AstraZeneca and Pfizer in Sweden? submit them here

15-Oct-2014 -   [View the story "Hej Sweden: in-Pharmatechnologist talks production strategy with AstraZeneca and Pfizer" on Storify]

News from CPhI

DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIs

14-Oct-2014 - Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers.

US FDA approves Gilead's $1,125 a pill combination Hep C drug

14-Oct-2014 - Gilead says its hepatitis C combination drug Harvoni will deliver significant healthcare savings in the long-term despite its $1,150 (€885) a pill price tag.

News from CPhI

Halal: accessing the untapped $30bn pharma market

13-Oct-2014 - The pharmaceutical industry must change its ingredients and manufacturing methods to cash in on the enormous purchasing power of European Muslims, says an expert.

Texas A&M licenses Xoma mobile clean room tech citing cost savings and flexibility

10-Oct-2014 - US academics have licensed a mobile clean room design from Xoma for a vaccine and medical countermeasure plant being built in Texas as part of an HHS-funded project.

Highly potent APIs: can lean manufacturing ever be safe?

09-Oct-2014 - The phrase “lean manufacturing” conjures up job cuts and not much more for many people, but managers can use the method to drastically simplify HPAPI (highly potent active pharmaceutical ingredients) production, says an expert.

QbD essential as tablet makers shift to continuous production, says Freeman

09-Oct-2014 - Drugmakers will “inevitably” shift from batch to continuous production of tablets and, according to Freeman Technology, a quality by design (QbD) approach is a fundamental requirement.

Used processing equipment industry booming due to pharma M&A, say vendors

08-Oct-2014 - Consolidation in the pharma industry is driving the second-hand processing equipment market but despite attempts to regulate the industry, a glut of online vendors means illegal drugmakers can buy such systems.

Lonza goes with the Flow Chemistry with latest API platform

07-Oct-2014 - Lonza has launched an API-making platform that uses chemical microreaction technology for continuous processing.

'Explosive' video from TechnoPharm

Safety concerns not blown out of proportion as APIs become more volatile, says Rembe

06-Oct-2014 - Including explosion protection in initial facility plans can save money in the long-term, according to Rembe, especially as drugmakers continue to work with more volatile ingredients.

Workers' fears come to fruition as Hospira receives US FDA Warning at Aus plant

06-Oct-2014 - Hospira has received a US FDA Warning Letter at an Australian injectables facility months after workers asked the firm not turn the site into “the new Rocky Mount.”

dispatches from technopharm

Malvern launches imaging tool for its laser diffraction tech

02-Oct-2014 - A laser diffraction imaging tool could be used by quality controllers to help measure particle size in a suspension according to Malvern Instruments.

Boehringer Ingelheim invests more than €100m to expand manufacturing capacity in Germany

02-Oct-2014 - Boehringer Ingelheim is investing more than €100m ($126m) at its Dortmund, Germany site to expand production capacity for its Respimat inhaler, which is the third time in the past four years that the company has made a capacity-expanding investment at the site.

Vorsprung durch TechnoPharm: Pharma tech firms head to Nuremberg

29-Sep-2014 - in-Pharmatechnologist.com is live from Nuremberg to bring you the best from TechnoPharm and POWTECH 2014, Europe's largest processing and powder shows.

Partnership looks to expand UK drug manufacturing

25-Sep-2014 - The Medicines Manufacturing Industry Partnership (MMIP) between the ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association) and a number of companies aims to make the UK a more attractive destination for pharma manufacturing. 

CORRECTION

Boehringer cutting German workforce by 600 but production jobs safe for now

24-Sep-2014 - Hundreds of workers brought in to help fix manufacturing issues at a Boehringer Ingelheim facility will not be affected despite the firm looking to shave 600 jobs in a €450m ($580m) cost-cutting initiative.

Generic Sovaldi makers could pocket upwards of $600m says analyst

24-Sep-2014 - The market opportunity for each Indian drugmakers granted a license to manufacture Gilead’s hepatitis C drug Sovaldi could be worth over $600m, an analyst has calculated.

Novartis cuts 83 more jobs at closing NY Diovan plant

23-Sep-2014 - Novartis has announced a second round of lay-offs at its manufacturing site in Suffern, New York ahead of the plant’s closure in 2016.

Pfizer and Irish port authorities working to stop API plant gathering dust

22-Sep-2014 - Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.

News in brief

Merck Serono teams with Lupin to bring drugs to emerging markets

17-Sep-2014 - Merck Serono has struck a deal with Indian drugmaker Lupin to bring a number of drugs for cardiovascular and diabetes diseases to emerging markets.

Hospira bucks Australian generics downturn with $14m investment

17-Sep-2014 - Hospira has invested 15m AUD ($14m) in a Victoria injectables plant it says will continue to make drugs for export despite the economic downturn and strong Australian dollar.

Spotlight

Share API audits or see quality slump, says Hovione

Share API audits or see quality slump, says Hovione

The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert...

Personalised meds to deliver bigger market for oral film technologies says expert
dispatches from technopharm

Personalised meds to deliver bigger market for oral film technologies says expert

Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts...

Complex regs and unknown markets top API shippers' logistics headaches
Pre CPhI Special

Complex regs and unknown markets top API shippers' logistics headaches

The world is getting larger, at least it is in terms of the pharmaceutical industry, according to...

How green was my Valium? Not very, despite industry claims
Pre CPhI Special

How green was my Valium? Not very, despite industry claims

Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to...

WHO welcomes industry response to Ebola crisis but calls for new drugs

WHO welcomes industry response to Ebola crisis but calls for new drugs

The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid...

Say ‘cheese’: database collects pill photos

Say ‘cheese’: database collects pill photos

The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database...

Key Industry Events

 

Access all events listing

Our events, Events from partners...